Gwinnett Clinical Research Center

What is Clinical Research?

Clinical pharmacology research is the process whereby medications are tested and approved for use in the treatment of various medical conditions. All medications must pass through prolonged, rigorous testing prior to their approval for prescription use in the U.S. population by the Food and Drug Administration (FDA). In order to obtain such approval, pharmaceutical companies ask physicians to recruit willing patients with medical conditions that are expected to respond to new medications. Hence, clinical pharmacology research offers patients the opportunity to experience the effects of new drugs prior to their release to the general public.

Gwinnett Clinical Research Center has been performing studies, assisting in the testing and development of new dermatologic medications for over 20 years. Some of the major advancements in dermatologic therapy have been offered to and experienced by our patients, over the years. The Research Center, located in our Snellville office, is owned and operated by Dr. Joel S. Shavin and Dr. Jonathan S. Weiss. They are assisted by two Research Coordinators, Linda Davis, MA, CRC, and Lesley McNeil, RN, CRC. All studies are conducted under the guidelines of Good Clinical Practices (GCPs), under Institutional Review Board (IRB) oversight, and according to the rules and regulations of the FDA.

Coordinators

Linda Davis, MA, CRC	MA degree, Athens Technical College, 1999 ACRP Clinical Research Coordinator Training, 2002 Dermatology and geriatric psychiatry research experience, 7 years Member, Association of Clinical Research Professionals (ACRP)
Lesley McNeil, RN, CRC	Associates of Science degree. College of Health Sciences, 1996 Phi Theta Kappa, 1996 Registered Nurse Degree, 1996 Clinical Research Professional, Beginning and Advanced Certificate, Gwinnett Technical College, 2005-2006 Member, Association of Clinical Research Professionals (ACRP)

Current Studies

We are seeking qualified patients for the following clinical research studies:

CURRENTLY ENROLLING

• ACNE - Moderate to severe acne using an oral medication.
• PSORIASIS - Moderate to severe psoriasis study using a topical treatment.
• BASAL CELL CARCINOMA - Cream applied twice a day to affected area except face, head and neck.

UPCOMING STUDIES

• PSORIASIS - Moderate to severe psoriasis using an injectable treatment.
• ACNE - Moderate to severe psoriasis study using a topical treatment.
• ONYCHOMYCOSIS - Oral anti-fungal treatment for toenail fungus.

Qualified participants will receive study related visits and study medication free of charge. Also, most of our studies offer compensation for your time and travel.
                            

Call Linda or Lesley at 770-972-2241 for more information.

Contact Us

Linda Davis, MA, CRC, or Lesley McNeil, RN, CRC
Gwinnett Clinical Research Center, Inc.
2383 Pate Street, N
Snellville, GA 30078
Tel: 770-972-2241
Fax: 770-972-7955
gcrcinc@bellsouth.net